Collaborative study on the expression of irregular erythrocyte antibody following erythrocyte transfusio
Not Applicable
Recruiting
- Conditions
- Patients received blood transfusion
- Registration Number
- JPRN-UMIN000036980
- Lead Sponsor
- Japan Erythrocyte Irregular Antibody Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
1) Rejected his/her informed consent after started this study. 2) The institutional head makes negative decision on this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Erythrocyte irregular antibodies detected following blood transfusion. 2) Factors related seroconversion of antibody following blood transfusion, including sex, age, primary disease, previous transfusion history, amounts of erythrocyte transfused (units) etc.
- Secondary Outcome Measures
Name Time Method